How to Check Catalyst Risk Before Selling Options

Disclosure: TickerRisk publishes this page and is one of the tools mentioned. We have tried to be straight about what each free source does better, because a guide that funnels you to one product regardless of the job is not worth reading.

The short answer

“Catalyst risk” is the chance that a scheduled event moves the stock through your strike before expiry. There are five that matter for options sellers, and no single free tool covers all of them:

• Earnings — an earnings calendar (Nasdaq, Earnings Whispers) or your broker.
• FDA decisions and clinical readouts — the FDA calendar, BioPharmaCatalyst, or ClinicalTrials.gov.
• Legal and litigation — court dockets (CourtListener / PACER), which almost nobody checks.
• SEC events — EDGAR filings.
• Elevated implied volatility — the tell that the market already knows something is coming.

If you only ever check one thing, check earnings — it is the most common trap and the easiest to see. If you want the whole calendar rolled into one number tied to your expiry, that is the specific job TickerRisk was built for. Both are covered below.

Why the premium is the warning

Option premium is priced off implied volatility, and implied volatility rises when the market expects a bigger move. A scheduled event — an earnings report, an FDA approval decision, a trial verdict — is the single most common reason for that expectation. So the stocks paying the fattest premium are disproportionately the ones with a catalyst sitting in the window.

That is the trap for premium sellers: you screen for high yield, the high-yield names float to the top, and you have quietly built a list of stocks that are about to gap. A high annualised return is a question, not an answer. The question is why is it that high.

The five checks, and where to run each

1. Earnings — do this every time

Any earnings calendar works: Nasdaq, Earnings Whispers, Investing.com, or your broker. The only thing that matters is whether the report falls on or before your expiry date. Barchart goes one better for options specifically — its screener has a “Flag Earnings” option that marks any contract whose next earnings date is on or before expiration. If earnings is the only event you care about, that covers it for free, from a source with far more history than us.

2. FDA and clinical — if you touch healthcare or biotech

Biotech is where catalyst risk is most violent: a single FDA decision can move a stock 40% overnight, and the option premium beforehand is enormous for exactly that reason. BioPharmaCatalyst and the FDA calendar track PDUFA dates and decisions; ClinicalTrials.gov lists trial milestones. Market Chameleon is the strongest mainstream options tool here — it tracks biotech catalysts and links them directly to option chains. If you trade biotech volatility, look at Market Chameleon before ours.

3. Legal and litigation — the one almost nobody checks

A court ruling, a class-action verdict or a major hearing can move a stock as hard as earnings, and there is no popular consumer tool that flags it against an options calendar. The raw source is CourtListener (free) or PACER (federal dockets). This is genuinely unusual to check by hand, which is precisely why it is an edge — and why we built it in.

4. SEC events — the paper trail

EDGAR is the free, authoritative source for SEC filings. An 8-K, a delayed filing, an insider-selling cluster or a going-concern note can all precede a move. It is public and searchable; the friction is that you have to go look, per ticker.

5. Implied volatility — the cross-check

Even without knowing the specific event, unusually high IV Rank tells you the market is pricing one in. If a stock’s IV Rank is near the top of its range and you cannot find the reason, assume you are missing something and dig before you sell. Most screeners — Barchart, Option Samurai, Market Chameleon, ours — show IV Rank.

The tools at a glance

Where TickerRisk fits

Ours, so read this with appropriate suspicion. The gap it fills is that the five checks above live in five different places, and running them per candidate is tedious enough that most people skip all but earnings. TickerRisk scores every S&P 500 ticker 0–100 across all five event types for a specific expiry window, and filters wheel and covered-call candidates on that score instead of showing it as an optional column.

The part that a single static number cannot express is that the score changes with your expiry. On one day in July 2026, Apple scored 51/100 (MEDIUM) over a one-week window and 97/100 (HIGH) over four weeks, because earnings fell in week three. Sell the weekly and the report is not your problem; sell the monthly and you sold straight through it.

Where it falls short, plainly: option premiums come from a delayed feed, not live NBBO, and are estimated where no bid exists (flagged in the output) — confirm in your broker before trading. Coverage is the S&P 500 plus common ETFs, not every optionable stock. Legal and SEC signals are drawn from public sources (CourtListener, EDGAR) and inherit the gaps in public data. And the options filter set is deliberately smaller than Barchart’s. If you already run all five checks by hand, you may not need us; if you skip four of them because it is a chore, that is the chore we removed.

A simple pre-trade routine

1. Find your candidate on any screener you like.
2. Check earnings against your expiry date — every single time.
3. If it is healthcare/biotech, check FDA and clinical dates.
4. If the IV Rank is unusually high and you cannot see why, treat that as a red flag and look at EDGAR and recent news before committing.
5. Only then decide whether the premium is compensation for risk you understand, or a trap.

The tool matters less than the habit. Every gap-down story starts with someone who did not check the calendar.

Run the whole check at once

Our wheel scanner applies the catalyst score to this week’s cash-secured put candidates, and you can scan any S&P 500 ticker over your exact expiry on the home page. Related reading: how to check earnings risk before selling options and the best cash-secured put screeners in 2026.